Neuroimmunomodulation in Depression: a Review of Inflammatory Cytokines Involved in This Process

Overview

Journal Neurochem Res

Specialties Chemistry
Neurology

Date 2014 Jul 6

PMID 24996933

Citations 10

Authors

Helena M Abelaira

Gislaine Z Reus

Fabricia Petronilho

Tatiana Barichello

Joao Quevedo

Affiliations

Soon will be listed here.

Abstract

Depression is a debilitating mental disease that affects a large number of people globally; however the pathophysiological mechanisms of this disease remain incompletely understood. Some studies have shown that depression is associated with inflammatory activity, and the mode of action of several antidepressants appears to involve immunomodulation. In this case, the induction of a pro-inflammatory state in healthy or depressive subjects induces a 'sickness behaviour' resembling depressive symptomatology. Potential mechanisms of pro-inflammatory cytokines are effects on monoamine levels, disruption of the hypothalamic-pituitary-adrenal axis, activation of the pathological microglial cells, such as the macrophages and alterations in neuroplasticity and brain functions. Thus, this review will highlight the role of inflammation in depression, the possible mechanisms involved, and also explore effective treatments that act on the immune system.

Citing Articles

Navigating the Neuroimmunomodulation Frontier: Pioneering Approaches and Promising Horizons-A Comprehensive Review.

Krsek A, Ostojic L, Zivalj D, Baticic L Int J Mol Sci. 2024; 25(17).

PMID: 39273641 PMC: 11396210. DOI: 10.3390/ijms25179695.

Identifying depression's genetic role as a precursor to sepsis and increased mortality risk: Comprehensive insights from mendelian randomization analysis.

Zhou Q, Shen Q, Chen X, Yang L, Ma Q, Chu L PLoS One. 2024; 19(5):e0300275.

PMID: 38805405 PMC: 11132443. DOI: 10.1371/journal.pone.0300275.

Inflammatory Pathogenesis of Post-stroke Depression.

Feng X, Ma X, Li J, Zhou Q, Liu Y, Song J Aging Dis. 2024; .

PMID: 38377025 PMC: 11745428. DOI: 10.14336/AD.2024.0203.

Social Isolation: A Narrative Review on the Dangerous Liaison between the Autonomic Nervous System and Inflammation.

Scata C, Carandina A, Della Torre A, Arosio B, Bellocchi C, Rodrigues G Life (Basel). 2023; 13(6).

PMID: 37374012 PMC: 10301441. DOI: 10.3390/life13061229.

Comorbidity Between Recent Diagnosis of Type 2 Diabetes and Non-Psychotic Psychiatric Disorders: Metabolic Characteristics and Clinical Correlates.

Alcantara-Garces M, Rodriguez-Ramirez A, Garcia-Ulloa A, Hernandez-Jimenez S Neuropsychiatr Dis Treat. 2022; 18:1151-1163.

PMID: 35719862 PMC: 9202562. DOI: 10.2147/NDT.S364556.

References

Levine J, Cholestoy A, Zimmerman J . Possible antidepressant effect of minocycline. Am J Psychiatry. 1996; 153(4):582. DOI: 10.1176/ajp.153.4.582b. View

Gibertini M, Newton C, Friedman H, Klein T . Spatial learning impairment in mice infected with Legionella pneumophila or administered exogenous interleukin-1-beta. Brain Behav Immun. 1995; 9(2):113-28. DOI: 10.1006/brbi.1995.1012. View

Bluthe R, Michaud B, Poli V, Dantzer R . Role of IL-6 in cytokine-induced sickness behavior: a study with IL-6 deficient mice. Physiol Behav. 2000; 70(3-4):367-73. DOI: 10.1016/s0031-9384(00)00269-9. View

Yoshimura R, Hori H, Ikenouchi-Sugita A, Umene-Nakano W, Ueda N, Nakamura J . Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression. Prog Neuropsychopharmacol Biol Psychiatry. 2009; 33(4):722-6. DOI: 10.1016/j.pnpbp.2009.03.020. View

Larson S, Dunn A . Behavioral effects of cytokines. Brain Behav Immun. 2002; 15(4):371-87. DOI: 10.1006/brbi.2001.0643. View

Patel A . Review: the role of inflammation in depression. Psychiatr Danub. 2013; 25 Suppl 2:S216-23. View

Pineda E, Hensler J, Sankar R, Shin D, Burke T, Mazarati A . Interleukin-1β causes fluoxetine resistance in an animal model of epilepsy-associated depression. Neurotherapeutics. 2012; 9(2):477-85. PMC: 3337012. DOI: 10.1007/s13311-012-0110-4. View

Simen B, Duman C, Simen A, Duman R . TNFalpha signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biol Psychiatry. 2006; 59(9):775-85. DOI: 10.1016/j.biopsych.2005.10.013. View

Raison C, Rutherford R, Woolwine B, Shuo C, Schettler P, Drake D . A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry. 2012; 70(1):31-41. PMC: 4015348. DOI: 10.1001/2013.jamapsychiatry.4. View

10.

Kent S, Bluthe R, Dantzer R, Hardwick A, Kelley K, Rothwell N . Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. Proc Natl Acad Sci U S A. 1992; 89(19):9117-20. PMC: 50076. DOI: 10.1073/pnas.89.19.9117. View

11.

Shenoy A, Dehmel T, Stettner M, Kremer D, Kieseier B, Hartung H . Citalopram suppresses thymocyte cytokine production. J Neuroimmunol. 2013; 262(1-2):46-52. DOI: 10.1016/j.jneuroim.2013.06.006. View

12.

Malynn S, Campos-Torres A, Moynagh P, Haase J . The pro-inflammatory cytokine TNF-α regulates the activity and expression of the serotonin transporter (SERT) in astrocytes. Neurochem Res. 2013; 38(4):694-704. DOI: 10.1007/s11064-012-0967-y. View

13.

Felger J, Lotrich F . Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience. 2013; 246:199-229. PMC: 3741070. DOI: 10.1016/j.neuroscience.2013.04.060. View

14.

Reus G, Dos Santos M, Abelaira H, Ribeiro K, Petronilho F, Vuolo F . Imipramine reverses alterations in cytokines and BDNF levels induced by maternal deprivation in adult rats. Behav Brain Res. 2012; 242:40-6. DOI: 10.1016/j.bbr.2012.11.044. View

15.

Goshen I, Kreisel T, Ben-Menachem-Zidon O, Licht T, Weidenfeld J, Ben-Hur T . Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry. 2007; 13(7):717-28. DOI: 10.1038/sj.mp.4002055. View

16.

Suvisaari J, Mantere O . Inflammation theories in psychotic disorders: a critical review. Infect Disord Drug Targets. 2013; 13(1):59-70. DOI: 10.2174/18715265112129990032. View

17.

OBrien S, Scully P, Fitzgerald P, Scott L, Dinan T . Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J Psychiatr Res. 2006; 41(3-4):326-31. DOI: 10.1016/j.jpsychires.2006.05.013. View

18.

Yirmiya R . Depression in medical illness: the role of the immune system. West J Med. 2000; 173(5):333-6. PMC: 1071158. DOI: 10.1136/ewjm.173.5.333. View

19.

Kubera M, Obuchowicz E, Goehler L, Brzeszcz J, Maes M . In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2010; 35(3):744-59. DOI: 10.1016/j.pnpbp.2010.08.026. View

20.

Dantzer R . Cytokine-induced sickness behavior: mechanisms and implications. Ann N Y Acad Sci. 2002; 933:222-34. DOI: 10.1111/j.1749-6632.2001.tb05827.x. View